Oaktree Capital Management »

Neogenomics shares owned by Oaktree Capital Management

Quarter-by-quarter ownership of Neogenomics shares owned by Oaktree Capital Management from 13F filings

Historical chart of Oaktree Capital Management investment in Neogenomics

Tip: Access up to 7 years of quarterly data

All positions including Neogenomics held by Oaktree Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neogenomics by Oaktree Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.4M 6.1M 0.72
2023-06-30 $9.1M 12M 0.74
2023-03-31 $9.0M 12M 0.74
2022-12-31 $3.8M 5.8M 0.66
2022-09-30 $959k 1.5M 0.65
2022-03-31 $535k 817k 0.65
2021-03-31 $3.3M 3.3M 1.01

More positions owned by Oaktree Capital Management

Torm Common Stock (TRMD)
Chesapeake Energy Corp Common Stock (CHK)
Garrett Motion Common Stock (GTX)
Sitio Royalties Corp Common Stock (STR)
Star Bulk Carriers Corp Common Stock (SBLK)
Vistra Corp Common Stock (VST)
Runway Growth Finance Corp Common Stock (RWAY)
Spdr S&p Oil & Gas Exploration & Production Etf Etf Put Option (XOP)
Nmi Holdings Common Stock (NMIH)
Vale Sa Common Stock (VALE)
Caterpillar Common Stock Put Option (CAT)
Infinera Corp Common Stock (INFN)
Freeport-mcmoran Common Stock (FCX)
Petroleo Brasileiro Sa Common Stock (PBR)
Cemex Sab De Cv Common Stock (CX)

View all positions for Oaktree Capital Management

Top funds holding Neogenomics

Braidwell
Calamos Advisors
D. E. Shaw & Co
Goldman Sachs Group
Franklin Resources
Capstone Investment Advisors
Tenor Capital Management
Deutsche Bank Aktiengesellschaft
New York State Common Retirement Fund
Steelhead Partners
CSS
Russell Investments
Credit Suisse
Calamos Wealth Management
Citigroup

View all funds holding Neogenomics